Pathogenic LRRK2 variants are gain-of-function mutations that enhance LRRK2-mediated repression of beta-catenin signaling

Berwick, D C and Javaheri, B and Wetzel, A and Hopkinson, M and Nixon-Abell, J and Granno, S and Pitsillides, A A and Harvey, K (2017) Pathogenic LRRK2 variants are gain-of-function mutations that enhance LRRK2-mediated repression of beta-catenin signaling. Molecular Neurodegeneration, 12 (9).

[img]
Preview
Text
10752.pdf - Published Version
Available under License Creative Commons Attribution.

Download (1MB) | Preview

Actions (Repository Editors)

View Item View Item